Abstract: The present invention relates to anionic photoinitiator compounds, compositions containing them, and methods of using them having the structure: ##STR1## wherein X and Y are independently selected from the group consisting of a direct single bond and --C(.dbd.O)--, wherein at least one of X and Y is --C(.dbd.O)--;R.sup.1 and R.sup.2 are independently selected from the group consisting of H and substituted phenyl, wherein both R.sup.1 and R.sup.2 are not H;and wherein neither --X--R.sup.1 nor --Y--R.sup.2 is --C(.dbd.O)H. The anionic photoinitiators have improved storage stability, without loss of photosensitivity, even when stored with polymerizable or crosslinkable monomer, oligomer, or crosslinkable polymer species.

Abstract: Administration of one or more of glutathione, its disulfide dimer, ascorbate-2-phosphate, or N-acetyl-L-cysteine, with or without antioxidants, is suitable for the treatment of influenza virus infection, as well as prophylactic prevention of influenza virus infection.

Abstract: Canine IL-1 receptor antagonist protein, DNAs, and expression vectors carrying DNA sequence encoding canine IL-1 receptor antagonist are disclosed.

Abstract: A system, apparatus and method for determining prognosis in atrial fibrillation non-invasively detects electrical activity of the heart with external electrodes, such as with ECG leads. The diagnostic system, apparatus and method provide a non-invasive technique to classify the severity of atrial fibrillation according to measured values of at least one predetermined parameter of the fibrillation as observed in the frequency domain. One predetermined parameter which is measured for the purpose of classification is peak frequency. Another predetermined parameter used for atrial fibrillation classification is a change in power along the range of frequencies.

Abstract: A liquid composition for the controlled release of gonodotropin releasing hormone (GnRH) or its analogs is provided that includes: (i) a non-polymeric, non-water soluble liquid carrier material (HVLCM) of viscosity of at least 5,000 cP at 37.degree. C. that does not crystallize neat under ambient or physiological conditions; and (ii) GnRH or analogs thereof.

Abstract: Canine IL-1 receptor antagonist protein, DNAs, and expression vectors carrying DNA sequence encoding canine IL-1 receptor antagonist are disclosed.

Abstract: Inorganic fibers are disclosed, vacuum preforms of which have a shrinkage of 3.5% or less when exposed to 1260.degree. C. for 24 hours. The fibers have a composition comprising SrO, Al.sub.2 O.sub.3, and sufficient fiber forming additive to allow fiber formation but not so much as to increase shrinkage beyond 3.5%. A preferred range of fibers has a shrinkage of 3.5% or less when exposed to 1500.degree. C. for 24 hours and may comprise (in weight percent): SrO 53.2%-57.6%, Al.sub.2 O.sub.3 30.4-40.1%, SiO.sub.2 5.06-10.1%.

Abstract: A composition as a medical or surgical device is provided that includes: (i) a non-polymeric, non-water soluble liquid carrier material (HVLCM) of viscosity of at least 5,000 cP at 37.degree. C. that does not crystallize neat under ambient or physiological conditions; and, optionally, (ii) a substance to be delivered.

Abstract: The invention relates to a water purification composition including silver metal and a second metal. The second metal is relatively reducing and helps control the overall silver cation concentration in solution. The composition effectively disinfects and removes toxic metal ions from water.

Abstract: A saline soluble fiber is disclosed that is highly refractory. A vacuum cast preform of the fiber has a shrinkage of 3.5% or less when exposed to 1260.degree. C. for 24 hours. The fiber may comprise CaO, SiO.sub.2, MgO, optionally ZrO.sub.2, optionally less than 0.75 mol % Al.sub.2 O.sub.3, any incidental impurities amounting to less than 2 mol % in total, and in which the SiO.sub.2 excess (defined as the amount of SiO.sub.2 calculated as remaining after the above named constituents are crystallized as silicates) exceeds 21.8 mol %, with the proviso that, if the amount of CaO is greater than the sum of the amount of MgO and twice the amount of ZrO.sub.2 the calculated ratio of diopside to wollastonite does not lie in the range 0.1 to 5.22. Such fibers are usable at elevated temperatures where refractoriness is of importance and their solubility in saline solution may make the fibers safer than non-soluble fibers.

Abstract: An infusion cannula for use in clearing and preventing condensation on the posterior surface of an artificial lens during the fluid-gas exchange portion of a pars plana vitrectomy is described. The infusion cannula directs the flow of gas entering the eye toward the posterior surface of the lens. The moisture content of the gas supplied to the infusion cannula is minimized in order to increase the effectiveness with which condensation is removed or prevented. Additionally, the temperature of the gas supplied to the infusion cannula is controlled to further increase the effectiveness with which condensation is removed.

Abstract: This invention relates to preservative compositions which comprise a biocidal metal compound and an fungicidal compound containing a triazole group. Methods of treating wood with the composition are also described.

Abstract: A method of purifying water includes contacting water containing an oxide of chlorine, such as chlorine dioxide, chlorite, or chlorate, with a water purification composition that includes a Group 11 or Group 12 metal such as silver, copper, or zinc.

Abstract: A saline soluble fibre is disclosed that is highly refractory. A vacuum cast preform of the fibre has a shrinkage of 3.5% or less when exposed to 1260.degree. C. for 24 hours. The fibre may comprise CaO, SiO.sub.2, MgO optionally ZrO.sub.2, optionally less than 0.75 mol % Al.sub.2 O.sub.3, any incidental impurities amounting to less than 2 mol % in total, and in which the SiO.sub.2, excess (defined as the amount of SiO.sub.2 calculated as remaining after the above named constituents are crystallised as silicates) exceeds 21.8 mol %, with the proviso that, if the amount of CaO is greater than the sum of the amount of MgO and twice the amount of ZrO.sub.2 the calculated ratio of diopside to wollastonite does not lie in the range 1.8 to 5.25. Such fibres are usable at elevated temperatures where refractoriness is of importance and their solubility in saline solution may make the fibres safer than non-soluble fibres.

Abstract: A method for the adjustment of pH in textile processing or other solutions, including recreational waters, that includes the use of urea sulfate or its equivalent.

Abstract: Inorganic fibers which have a silicon extraction of greater than about 0.02 wt % Si/day in physiological saline solutions. The fiber contains SiO.sub.2, MgO, CaO, and at least one of Al.sub.2 O.sub.3, ZrO.sub.2, TiO.sub.2, B.sub.2 O.sub.3, iron oxides, or mixtures thereof. Also disclosed are inorganic fibers which have diameters of less than 3.5 microns and which pass the ASTM E-119 two hour fire test when processed into a fiber blanket having a bulk density in the range of about 1.5 to 3 pcf.

Abstract: High friction coatings, compositions for producing such coatings, and non-skid coatings for ships and decks are disclosed. Included are compositions comprising a curable resin, a filler, and aramid in the form of fibers or flakes.

Abstract: The instant invention concerns a wood preservative composition comprising a synergistically effective amount of (a) a cuprammonium compound and (b) tebuconazole to preserve wood.